Select for export Pholiotina cyanopus, a rare fungus producingpsychoactive tryptamines Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1515/biol-2015-0005 Copy citation Copy BibTeX Open Life Sciences 2014-11-18 Marek Halama, Anna Poliwoda, Іzabela Jasicka-Misiak, Piotr Wieczorek, Ryszard Rutkowski OpenAlex Published psilocybinpsilocin PharmacologyToxicity Other More
Select for export P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(14)70316-5 Copy citation Copy BibTeX European Neuropsychopharmacology 2014-09-24 Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider OpenAlex Published psilocybin Brain ImagingReceptor PharmacologyEmotional Processing Other More
Select for export Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114548296 PubMed 25213996 Copy citation Copy BibTeX Journal of Psychopharmacology 2014-09-10 Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Europe PMC Published psilocybin AddictionReceptor PharmacologyBiomarkers Other More
Select for export TINJAUAN PELAKSANAAN KETENTUAN PIDANA UNDANGUNDANG NOMOR 35 TAHUN 2009 TERHADAP PENYALAHGUNAAN MAGIC MUSHROOM Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX UAJY Repository (University of Southampton) 2014-03-12 Damianus Diaz Ferianto OpenAlex Published psilocybin Chronic PainPharmacologyConsciousness Other More
Select for export EPA-1211 - Role of 5-HT2a and mglu2 as a gpcr heterocomplex in antipsychotic action Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(14)78457-3 Copy citation Copy BibTeX European Psychiatry 2013-12-31 Javier González-Maeso OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Other More
Select for export Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113513852 PubMed 24284475 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-11-26 Winstock AR, Kaar S, Borschmann R. Europe PMC Published psilocybin Observational StudyAbuse Liability Observational Study More
Select for export Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113494107 PubMed 23784738 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-06-18 Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM. Europe PMC Published psilocybin Depression Other More
Select for export The Use of Synthetic Cathinones and Tryptamines in a Psychiatric Population Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4172/2325-9841.1000109 Copy citation Copy BibTeX Journal of Forensic Toxicology and Pharmacology 2012-12-31 lhsan M Salloum OpenAlex Published psilocybin PharmacologyToxicity Other More
Select for export The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-012-2811-0 PubMed 22836372 Copy citation Copy BibTeX Psychopharmacology 2012-07-26 Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. Europe PMC Published psilocybin Receptor PharmacologyEmotional Processing Other More
Select for export Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/hup.2234 PubMed 22696164 Copy citation Copy BibTeX Human Psychopharmacology Clinical and Experimental 2012-06-13 Licht CL, Christoffersen M, Okholm M, Damgaard L, Fink-Jensen A, Knudsen GM Europe PMC Published psilocybin AddictionObservational StudyAdolescents Observational Study More
Select for export Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms' Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Pure Amsterdam UMC 2012-05-31 Jacomien Aleman, Mirjam Crul, Peter H. J. van der Voort, Eric J. F. Franssen OpenAlex Published psilocybinpsilocin End-of-Life DistressPharmacologyReceptor Pharmacology Case Report More
Select for export Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1096/fasebj.26.1_supplement.1043.3 Copy citation Copy BibTeX The FASEB Journal 2012-03-31 Evan J. Kyzar, Christopher Collins, Jeremy Green, Siddharth Gaikwad, Andrew Roth, Louis Monnig OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Flavone Glycoside Antagonizes Psilocybin-Induced Toxicity by Reducing Oxidative Stress in Rats Model Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Zhongguo Yike Daxue xuebao 2011-12-31 LI Yu-bai OpenAlex Published psilocybin PharmacologyReceptor PharmacologyOxidative Stress Other More
Select for export Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881111420188 PubMed 21956378 Copy citation Copy BibTeX Journal of Psychopharmacology 2011-09-27 MacLean KA, Johnson MW, Griffiths RR. Europe PMC Published psilocybin Personality ChangeCreativitySpirituality Randomized Controlled Trial More
Select for export Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/npp.2011.228 PubMed 21956447 Copy citation Copy BibTeX Neuropsychopharmacology 2011-09-27 Quednow BB, Kometer M, Geyer MA, Vollenweider FX. Europe PMC Published psilocybinpsilocin Receptor PharmacologyConsciousnessObservational Study Clinical Trial More
Select for export P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(11)70495-3 Copy citation Copy BibTeX European Neuropsychopharmacology 2011-08-06 Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt OpenAlex Published psilocybin Mechanism of ActionCancer Patients Other More
Select for export Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-011-2358-5 PubMed 21674151 Copy citation Copy BibTeX Psychopharmacology 2011-06-14 Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Europe PMC Published psilocybin AnxietySpiritualityMystical Experience Clinical Trial More
Select for export Harm potential of magic mushroom use: a review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.yrtph.2011.01.006 PubMed 21256914 Copy citation Copy BibTeX Regulatory toxicology and pharmacology: RTP 2011-03-31 van Amsterdam J, Opperhuizen A, van den Brink W PubMed Published psilocybin Review ArticleSafetyToxicity Review Article More
Select for export Biophotons, hallucinogens, and fluorescence Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(11)72907-8 Copy citation Copy BibTeX European Psychiatry 2011-02-28 F. Grass OpenAlex Published psilocin Pharmacology Other More
Select for export Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881110388326 PubMed 21148021 Copy citation Copy BibTeX Journal of Psychopharmacology 2010-12-07 Halberstadt AL, Koedood L, Powell SB, Geyer MA. Europe PMC Published psilocybinpsilocin Receptor PharmacologyAnimal Study Animal Study More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.